GT Biopharma, Inc. — 8-K Filings
215 8-K filings on record
This page lists all 8-K filings submitted to the SEC by GT Biopharma, Inc. (GTBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. GT Biopharma, Inc. has filed 215 8-K documents with the SEC since 1995. To view all SEC filings by GT Biopharma, Inc., see the full filings list.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001493152-26-008442 | Mar 2, 2026 | Mar 1, 2026 |
| 8-K | 8-K | 0001493152-25-025162 | Nov 26, 2025 | Nov 20, 2025 |
| 8-K | 8-K | 0001493152-25-022631 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001493152-25-015725 | Sep 26, 2025 | Sep 25, 2025 |
| 8-K | 8-K | 0001493152-25-014684 | Sep 23, 2025 | Sep 17, 2025 |
| 8-K | 8-K | 0001493152-25-012479 | Aug 29, 2025 | Aug 26, 2025 |
| 8-K | 8-K | 0001641172-25-020847 | Jul 24, 2025 | — |
| 8-K | 8-K | 0001641172-25-014700 | Jun 11, 2025 | Jun 10, 2025 |
| 8-K | 8-K | 0001641172-25-012481 | May 27, 2025 | May 21, 2025 |
| 8-K | 8-K | 0001641172-25-009941 | May 13, 2025 | May 7, 2025 |
| 8-K | 8-K | 0001641172-25-009854 | May 13, 2025 | May 12, 2025 |
| 8-K | 8-K | 0001641172-25-008682 | May 5, 2025 | Apr 29, 2025 |
| 8-K | — | 0001641172-25-002750 | Apr 4, 2025 | Mar 31, 2025 |
| 8-K | — | 0001493152-25-008387 | Feb 26, 2025 | Feb 25, 2025 |
| 8-K | — | 0001493152-25-003707 | Jan 27, 2025 | — |
| 8-K | — | 0001493152-24-047994 | Nov 27, 2024 | Nov 21, 2024 |
| 8-K | — | 0001493152-24-047085 | Nov 21, 2024 | Nov 18, 2024 |
| 8-K | — | 0001493152-24-036381 | Sep 16, 2024 | — |
| 8-K | — | 0001493152-24-025382 | Jun 27, 2024 | — |
| 8-K | — | 0001493152-24-025269 | Jun 26, 2024 | Jun 25, 2024 |
| 8-K | — | 0001493152-24-023195 | Jun 7, 2024 | Jun 3, 2024 |
| 8-K | — | 0001493152-24-021078 | May 23, 2024 | May 21, 2024 |
| 8-K | — | 0001493152-24-017209 | Apr 30, 2024 | Apr 25, 2024 |
| 8-K | — | 0001493152-24-004587 | Feb 1, 2024 | — |
| 8-K | — | 0001493152-23-045714 | Dec 21, 2023 | Dec 18, 2023 |
| 8-K | — | 0001493152-23-043582 | Dec 4, 2023 | — |
| 8-K | — | 0001493152-23-029841 | Aug 22, 2023 | — |
| 8-K | — | 0001493152-23-023367 | Jul 5, 2023 | Jun 28, 2023 |
| 8-K | — | 0001493152-23-015385 | May 4, 2023 | May 1, 2023 |
| 8-K | — | 0001493152-23-006284 | Feb 28, 2023 | Feb 22, 2023 |
| 8-K | — | 0001493152-23-000198 | Jan 4, 2023 | Dec 30, 2022 |
| 8-K | — | 0001493152-22-035311 | Dec 13, 2022 | Dec 8, 2022 |
| 8-K | — | 0001493152-22-031139 | Nov 9, 2022 | Nov 3, 2022 |
| 8-K | — | 0001493152-22-028260 | Oct 12, 2022 | Oct 10, 2022 |
| 8-K | — | 0001493152-22-027568 | Oct 4, 2022 | — |
| 8-K | — | 0001493152-22-024422 | Aug 30, 2022 | Aug 24, 2022 |
| 8-K | — | 0001493152-22-016671 | Jun 14, 2022 | Jun 8, 2022 |
| 8-K | — | 0001493152-22-016394 | Jun 10, 2022 | Jun 9, 2022 |
| 8-K | — | 0001493152-22-006294 | Mar 8, 2022 | Mar 2, 2022 |
| 8-K | FORM 8-K | 0001654954-22-001828 | Feb 18, 2022 | Feb 14, 2022 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-013517 | Dec 23, 2021 | Dec 22, 2021 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-013424 | Dec 21, 2021 | Dec 15, 2021 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-012629 | Nov 26, 2021 | Nov 23, 2021 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-011550 | Nov 1, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-010321 | Sep 23, 2021 | Sep 17, 2021 |
| 8-K | CURRENT REPORT | 0001654954-21-009965 | Sep 13, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-006018 | May 19, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-004820 | Apr 29, 2021 | Apr 23, 2021 |
| 8-K | CURRENT REPORT | 0001654954-21-004293 | Apr 16, 2021 | Apr 14, 2021 |
| 8-K | CURRENT REPORT | 0001654954-21-001950 | Feb 22, 2021 | Feb 16, 2021 |